| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/13/2001 | CN1299274A Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 06/13/2001 | CN1299257A Use of corneal hardening agent in enzyme orthokeratology |
| 06/13/2001 | CN1299249A Reagent for tumor therapy and/or imaging |
| 06/13/2001 | CN1299235A Novel composition of eprosartan |
| 06/13/2001 | CN1299234A Method and compounds for the genetic treatment of hyperlipidemia |
| 06/13/2001 | CN1298874A Non-ball shaped and non-flake type mercapto pyridine oxide salts and preph. method therefor |
| 06/13/2001 | CN1298873A Xiantuopuli-hydrate as inhibitor of angiotonin converzyme |
| 06/13/2001 | CN1298872A Novel amino pyrroline compound, its prepn. method and pharmaceutical compositions contg. same |
| 06/13/2001 | CN1298871A 3-(fatty acid)-1,2 glceride disulfate and its preparing process and application |
| 06/13/2001 | CN1298869A Prourokinase and urokinase affinity ligand and its usage |
| 06/13/2001 | CN1298743A Low-poison efficient antineoplastic medicine and its preparing process |
| 06/13/2001 | CN1298739A Medicinal composition of treating asthma and pulmonary hypertension |
| 06/13/2001 | CN1298735A Musk plaster for bone-set |
| 06/13/2001 | CN1298727A Plaster for treating hyperosteogeny |
| 06/13/2001 | CN1298725A Ointment for treating burn and scald and its preparing process |
| 06/13/2001 | CN1298715A Hematopoietic oral liquid and its preparing process |
| 06/13/2001 | CN1298706A Kelarmycin eye drops and its preparing process |
| 06/13/2001 | CN1298705A Chinese medicine for treating hepatitis B and its preparing process |
| 06/13/2001 | CN1298704A Composite lifuding and preparing process |
| 06/13/2001 | CN1298703A Lubricating cream for copulation and its preparing process |
| 06/13/2001 | CN1298702A Water-soluble powder injection of ormosin VI and its preparing process and application |
| 06/13/2001 | CN1298701A Compound amino acid composition |
| 06/13/2001 | CN1298700A Brufen and its salts used for treating migraine method |
| 06/13/2001 | CN1298699A Quick acting aerosol for treating asthma and preparing process thereof |
| 06/13/2001 | CN1067082C Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 06/13/2001 | CN1067078C 2-beta-alkenyl penam sulfones, prepn. method and use thereof |
| 06/13/2001 | CN1067077C Erythromycin derivant and prepn. method and usage of medicine thereof |
| 06/13/2001 | CN1067076C Method for prepn. of substituted thiacycloalkeno [3,2-6] pyridines pharmaceutical compositions |
| 06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
| 06/13/2001 | CN1067074C Carbapenem antibiotic, composition and method of prepn. |
| 06/13/2001 | CN1067071C Carboline derivatives |
| 06/13/2001 | CN1067070C Coralyne analogs as topoisomerase inhibitors |
| 06/13/2001 | CN1067068C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067065C (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate |
| 06/13/2001 | CN1067057C Serotonin 5-HI1A and dopamin D2 receptor ligands |
| 06/13/2001 | CN1067054C 1H-indole-3-glyoxylamide 5 PLA 2 inhibitors |
| 06/13/2001 | CN1067053C Process for preparing intermediate of derivatives of monocyclic beta-lactam antibiotics |
| 06/13/2001 | CN1066964C Microcapsules, method of making same and their use |
| 06/13/2001 | CN1066961C Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin |
| 06/13/2001 | CN1066959C Medicine for treating hydocephalus |
| 06/13/2001 | CN1066939C Pharmaceutical composition contg. thiazolidine denvative and prepn. process-thereof |
| 06/13/2001 | CN1066930C Cholesterol lowering drink mixture compositions |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245914 Efficient method for the conversion of nitriles to amidines and species thereof |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245820 Method for treating Meniere's disease |
| 06/12/2001 | US6245819 Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause |
| 06/12/2001 | US6245818 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
| 06/12/2001 | US6245817 NPY5 receptor antagonists and methods for using same |
| 06/12/2001 | US6245815 Method of treating alcoholism and complications resulting therefrom |
| 06/12/2001 | US6245813 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 06/12/2001 | US6245812 Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245808 Oxy-vanadium (IV) complexes having spermicidal activity |
| 06/12/2001 | US6245807 Administering a diketonaphtho(2,3-b)pyran compound |
| 06/12/2001 | US6245806 HIV integrase inhibitors |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245803 Palatable elemental medical food |
| 06/12/2001 | US6245802 Method for treating pain |
| 06/12/2001 | US6245801 Branched alkyl pyrrolidine-3-carboxylic acids |
| 06/12/2001 | US6245800 Method of preventing or treating statin-induced toxic effects using L-carnitine or an alkanoyl L-carnitine |
| 06/12/2001 | US6245797 Administering mixture of enzyme inhibitors |
| 06/12/2001 | US6245796 Tricyclic pyrrole or pyrazole derivative |
| 06/12/2001 | US6245791 Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245789 HIV and viral treatment |
| 06/12/2001 | US6245788 Using 5-aryl-1,2,4-triadazol-3-yl (thio)urea compound |
| 06/12/2001 | US6245787 Composition containing amlodipine or a pharmaceutically acceptable salt thereof, and an ACE inhibitor |
| 06/12/2001 | US6245786 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 06/12/2001 | US6245783 Method of using neurotrophic sulfonamide compounds |
| 06/12/2001 | US6245782 Prevention reduction of serotonin in blood by administering sertralin, fluvoxamine, paroxetine or fluoxetine |
| 06/12/2001 | US6245781 Administering berberine |
| 06/12/2001 | US6245778 1,6-naphthyridine anti-convulsants |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245775 Anticholesterol agents; cardiovascular disorders |
| 06/12/2001 | US6245774 Tri-substituted phenyl or pyridine derivatives |
| 06/12/2001 | US6245773 Benign prostatic hyperplamia; reduction of intraocular pressure |
| 06/12/2001 | US6245770 Fungicidal pyrimidinones |
| 06/12/2001 | US6245769 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders |
| 06/12/2001 | US6245766 Method of treating psychiatric conditions |
| 06/12/2001 | US6245765 Psychological disorders |
| 06/12/2001 | US6245764 β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
| 06/12/2001 | US6245763 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/12/2001 | US6245760 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245758 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 06/12/2001 | US6245757 Reducing damage due to stroke or mycardium infarction; central nervous system and cardiovascular disorders |
| 06/12/2001 | US6245756 Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system |
| 06/12/2001 | US6245755 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 06/12/2001 | US6245753 Covalently bonded to cholic acid derivative sterol; anticoagulant coating for medical equipment |
| 06/12/2001 | US6245751 Administering peptide fragment as protease inhibitor; alzheimer*s disease treatment |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245749 Nucleosides with anti-hepatitis B virus activity |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245745 Bactericides and antiprotozoa agents |
| 06/12/2001 | US6245744 Antilipemic agents |
| 06/12/2001 | US6245563 Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |